Vagistat-1 is first OTC one-day vaginal yeast infection treatment.
This article was originally published in The Tan Sheet
Executive Summary
BRISTOL-MYERS SQUIBB VAGISTAT-1 ONE-DAY OTC VAGINAL YEAST INFECTION TREATMENT to launch by spring in drug, food and mass market merchandisers. BMS received approval for the OTC 6.5% tioconazole vaginal yeast infection ointment on Feb. 11. The company filed a supplemental NDA (20-676) for U.S. OTC use of tioconazole for vaginal yeast infections in November 1995. Vagistat-1 has been approved for OTC marketing in the U.K. since January 1994.